Ovation.io, Inc. (Ovation), makers of the fastest-growing clinical laboratory information and commercialization platform, today announced the close of an expanded $1.85M round of financing, initially led by StageDotO and Longfellow Ventures, as well as the completion of a partnership key to the development of its commercial platform. Ovation continues to evolve beyond a laboratory information management system (LIMS) to a full commercialization ecosystem that provides diagnostic labs with sample tracking, billing and reimbursement, reporting, document management, training management, client management, laboratory consulting services and business analytics. The company also announced that John Walker, Head of Core Data and Analytics, NIBR Informatics, Novartis, has joined its board of directors and that they have expanded their advisory panel to include Chad Robins, Rich Miller, and Vinay Gidwaney.
“We have shown that we can help diagnostic labs scale quickly by providing a platform that works across every element of a lab’s operations. By continuing to add best-in-class partners in critical functional areas and drawing innovation from our expanding support network of industry experts, Ovation is helping our customers to change the role of the diagnostic lab in clinical trials and the demonstration of real world evidence,” said Barry Wark, Chief Executive Officer of Ovation... READ MORE